144 related articles for article (PubMed ID: 1825025)
1. Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and Down's syndrome. A Pediatric Oncology Group study.
Ragab AH; Abdel-Mageed A; Shuster JJ; Frankel LS; Pullen J; van Eys J; Sullivan MP; Boyett J; Borowitz M; Crist WM
Cancer; 1991 Feb; 67(4):1057-63. PubMed ID: 1825025
[TBL] [Abstract][Full Text] [Related]
2. Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.
Dördelmann M; Schrappe M; Reiter A; Zimmermann M; Graf N; Schott G; Lampert F; Harbott J; Niemeyer C; Ritter J; Dörffel W; Nessler G; Kühl J; Riehm H
Leukemia; 1998 May; 12(5):645-51. PubMed ID: 9593260
[TBL] [Abstract][Full Text] [Related]
3. Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
Bassal M; La MK; Whitlock JA; Sather HN; Heerema NA; Gaynon PS; Stork LC
Pediatr Blood Cancer; 2005 Jan; 44(1):21-8. PubMed ID: 15368546
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ;
Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes in children with Acute lymphoblastic leukemia with versus without coexisting Down's syndrome: A systematic review and meta-analysis.
Liao W; Liu Y
Medicine (Baltimore); 2020 Jul; 99(29):e21015. PubMed ID: 32702842
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biological characteristics of acute lymphocytic leukemia in children with Down syndrome.
Kalwinsky DK; Raimondi SC; Bunin NJ; Fairclough D; Pui CH; Relling MV; Ribeiro R; Rivera GK
Am J Med Genet Suppl; 1990; 7():267-71. PubMed ID: 2149960
[TBL] [Abstract][Full Text] [Related]
7. Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.
Chessells JM; Harrison G; Richards SM; Bailey CC; Hill FG; Gibson BE; Hann IM
Arch Dis Child; 2001 Oct; 85(4):321-5. PubMed ID: 11567943
[TBL] [Abstract][Full Text] [Related]
8. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
9. Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.
Wheeler K; Chessells JM; Bailey CC; Richards SM
Arch Dis Child; 1996 Feb; 74(2):101-7. PubMed ID: 8660070
[TBL] [Abstract][Full Text] [Related]
10. Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome.
Shah N; Al-Ahmari A; Al-Yamani A; Dupuis L; Stephens D; Hitzler J
Pediatr Blood Cancer; 2009 Jan; 52(1):14-9. PubMed ID: 18802938
[TBL] [Abstract][Full Text] [Related]
11. Acute lymphoblastic leukemia in children with Down syndrome: Comparative analysis versus patients without Down syndrome.
Pennella CL; Rossi JG; Baialardo EM; Alonso CN; Guitter MR; Sánchez La Rosa CG; Millán NC; Alfaro EM; Zubizarreta PA; Felice MS
Arch Argent Pediatr; 2018 Aug; 116(4):e500-e507. PubMed ID: 30016023
[TBL] [Abstract][Full Text] [Related]
12. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
Gamis AS; Woods WG; Alonzo TA; Buxton A; Lange B; Barnard DR; Gold S; Smith FO;
J Clin Oncol; 2003 Sep; 21(18):3415-22. PubMed ID: 12885836
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognosis of children with Down's syndrome and leukaemia: a 34-year nation-wide experience.
Rajantie J; Siimes MA
J Intellect Disabil Res; 2003 Nov; 47(Pt 8):617-21. PubMed ID: 14641809
[TBL] [Abstract][Full Text] [Related]
14. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
Arico M; Ziino O; Valsecchi MG; Cazzaniga G; Baronci C; Messina C; Pession A; Santoro N; Basso G; Conter V;
Cancer; 2008 Aug; 113(3):515-21. PubMed ID: 18521927
[TBL] [Abstract][Full Text] [Related]
15. Unrelated donor bone marrow transplantation for acute leukemia in patients with Down's syndrome.
Pawlowska AB; Davies SM; Orchard PJ; Wagner JE; Ramsay NK
Bone Marrow Transplant; 1996 Aug; 18(2):453-5. PubMed ID: 8864463
[TBL] [Abstract][Full Text] [Related]
16. Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction.
Kojima S; Matsuyama T; Sato T; Horibe K; Konishi S; Tsuchida M; Hayashi Y; Kigasawa H; Akiyama Y; Okamura J
Blood; 1990 Dec; 76(11):2348-53. PubMed ID: 2147864
[TBL] [Abstract][Full Text] [Related]
17. A comparison of acute lymphoblastic leukemia in Down syndrome and non-Down syndrome children: the role of trisomy 21.
Tigay JH
J Pediatr Oncol Nurs; 2009; 26(6):362-8. PubMed ID: 20032297
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study.
Whitlock JA; Sather HN; Gaynon P; Robison LL; Wells RJ; Trigg M; Heerema NA; Bhatia S
Blood; 2005 Dec; 106(13):4043-9. PubMed ID: 16109782
[TBL] [Abstract][Full Text] [Related]
19. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
20. Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.
Zawitkowska J; Odój T; Drabko K; Zaucha-Prażmo A; Rudnicka J; Romiszewski M; Matysiak M; Kwiecińska K; Ćwiklińska M; Balwierz W; Owoc-Lempach J; Derwich K; Wachowiak J; Niedźwiecki M; Adamkiewicz-Drożyńska E; Trelińska J; Młynarski W; Kołtan A; Wysocki M; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Ociepa T; Urasiński T; Mizia-Malarz A; Sobol-Milejska G; Karolczyk G; Kowalczyk J
Pediatr Hematol Oncol; 2017 May; 34(4):199-205. PubMed ID: 29040012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
